Long-term safety and efficacy of bimekizumab in patients with active ankylosing spondylitis: 5-year results from a phase 2b study and its open-label extension
Author(s):
- Dr. Alexis Ogdie, MD, Professor of Medicine and Epidemiology in the Perelman School of Medicine
| Display Label | Action |
|---|---|
| RheumNow24_BE AGILE 5-Year S_E_AUDIO _1_ | Download Resource |
| RheumNow24_BE AGILE 5-Year S_E_Digital Submission _1_ | Download Handout |